In Global Health Research, Is It Legitimate to Stop Clinical Trials Early on Account of Their Opportunity Costs?

PLoS Medicine - United States
doi 10.1371/journal.pmed.1000071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Is It Legitimate and Beneficial for Judges to Compare?

2018English

Clinical Trials and International Health Research.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1979English

Dengue Vaccine Clinical Trials in India — An Opportunity to Inform the Global Response to a Re-Emerging Disease Challenge

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Taking Opportunity Costs Seriously in Public Health Law

Public Health Reports
EnvironmentalPublic HealthOccupational Health
2018English

Is It Time to Conduct Phase 3 Clinical Trials of Sex Hormones in MS – Commentary

Multiple Sclerosis
Neurology
2018English

When Is It Legitimate to Exclude Patients' Data From Study Results?

BMJ
2002English

Zika: Where It Has Been, Where It Is Going, and How to Stop It

International Journal of Clinical Practice
Medicine
2016English

Is It Time to Stop (Or Pause) Vertebral Augmentation?

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Clinical Trials in Developing Countries: Risk or Opportunity?

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy